| 210 |
increased |
hyperplasia
(MESH:D006965)
|
hepatic oval stem cell
(CL:0002196)
|
854: Alterations, Cellular proliferation / hyperplasia
|
| 209 |
abnormal |
cell proliferation
(GO:0008283)
|
Liver cell
(FMA:63179)
|
854: Alterations, Cellular proliferation / hyperplasia
|
| 208 |
occurrence |
|
Liver Diseases
(MESH:D008107)
|
139: N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects
|
| 207 |
decreased |
apoptotic process
(GO:0006915)
|
|
2 Events
|
| 206 |
abnormal |
cellular homeostasis
(GO:0019725)
|
|
853: Changes/Inhibition, Cellular Homeostasis and Apoptosis
|
| 205 |
increased |
signaling
(GO:0023052)
|
aryl hydrocarbon receptor
(PR:000003858)
|
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes
|
| 204 |
increased |
cell proliferation
(GO:0008283)
|
memory T cell
(CL:0000813)
|
272: Activation/Proliferation, T-cells
|
| 203 |
increased |
T cell activation
(GO:0042110)
|
T cell
(CL:0000084)
|
272: Activation/Proliferation, T-cells
|
| 202 |
increased |
MHC protein complex assembly
(GO:0002396)
|
|
398: Activation, Dendritic Cells
|
| 201 |
increased |
cell activation
(GO:0001775)
|
|
3 Events
|
| 200 |
increased |
cytokine production involved in inflammatory response
(GO:0002534)
|
|
826: Activation, Keratinocytes
|
| 199 |
increased |
keratinocyte activation
(GO:0032980)
|
|
826: Activation, Keratinocytes
|
| 198 |
increased |
protein binding
(GO:0005515)
|
electrophilic reagant
(CHEBI:59739)
|
396: Covalent Binding, Protein
|
| 197 |
increased |
Respiratory Hypersensitivity
(MESH:D012130)
|
|
313: Increase, Allergic Respiratory Hypersensitivity Response
|
| 196 |
increased |
cytokine activity
(GO:0005125)
|
Cytokine
(FMA:84050)
|
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
|
| 195 |
increased |
chemokine activity
(GO:0008009)
|
Chemokine
(FMA:241981)
|
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
|
| 194 |
increased |
covalent binding
(MI:0195)
|
xenobiotic
(CHEBI:35703)
|
75: N/A, Covalent binding to protein, possibly lysine residue
|
| 193 |
increased |
transforming growth factor beta1 production
(GO:0032905)
|
TGF-beta 1
(PR:000000182)
|
276: Up Regulation, TGFbeta1 expression
|
| 192 |
occurrence |
liver fibrosis
(MP:0003333)
|
liver
(UBERON:0002107)
|
2 Events
|
| 191 |
increased |
macrophage activation
(GO:0042116)
|
Kupffer cell
(CL:0000091)
|
134: Increase, Kupffer cell activation
|
| 190 |
increased |
protein alkylation
(GO:0008213)
|
|
244: Alkylation, Protein
|
| 189 |
increased |
hepatic stellate cell activation
(GO:0035733)
|
hepatic stellate cell
(CL:0000632)
|
265: Increase, Hepatic stellate cell activation
|
| 188 |
increased |
collagen biosynthetic process
(GO:0032964)
|
collagen
(CHEBI:3815)
|
68: Increase, Collagen accumulation
|
| 187 |
increased |
|
fatty liver
(MESH:D005234)
|
None
|
| 186 |
decreased |
3-hydroxyacyl-CoA dehydrogenase activity
(GO:0003857)
|
3-hydroxyacyl-CoA dehydrogenase type-2
(PR:000008774)
|
2 Events
|